台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效

易威

(1799)
  • 股價
    78.5
  • 漲跌
    ▲3.5
  • 漲幅
    +4.67%
  • 成交量
    512
  • 產業
    上櫃 生技醫療類股
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/05/10 ~ 2024/05/17     後一日»

券商獲利排行 - 2024/05/10 ~ 2024/05/17

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  3.20%321.30321.3132132076.176.1078.5
  4.26%243.80243.87676075.375.3078.5
  3.95%238.2-0.9239.17880275.475.47578.5
  1.17%228.40228.4252252077.677.6078.5
  5.17%142.80142.83737074.674.6078.5
  2.92%130.948.382.525593375.975.376.878.5
  3.34%119.30119.3474707676078.5
  3.08%89.539.150.418382076.475.777.778.5
  1.73%53.33.449.93240777.17777.578.5
  5.47%52.9052.91313074.474.4078.5
  5.61%37.5037.599074.374.3078.5
  3.97%30030910075.575.578.178.5
  3.29%25025101007676078.5
  2.82%23.87.616.2611476.776.278.178.5
  5.21%23.49.51436374.973.97778.5
  3.73%20.317.62.7-34777.87579.478.5
  5.28%19.7019.755074.674.6078.5
  0.39%19.1-38.557.62765387676.475.478.5
  8.48%18.4018.433072.472.4078.5
  3.75%14.32.911.445176.175.678.578.5
  3.04%142.511.446176.676.278.878.5
  1.18%13.6-3.517.11115476.876.976.178.5
  6.05%13.4013.43307474078.5
  3.40%12.9012.955075.975.9078.5
  1.46%12.52.99.6911277.777.478.978.5
  4.09%12.58.93.604376.274.977.978.5
  8.05%11.7011.722072.772.7078.5
  5.15%11.63.38.313175.474.377.678.5
  3.43%10.4010.444075.975.9078.5
  3.38%10.373.314376.275.277.578.5
  6.88%10.1010.122073.573.5078.5
  1.57%10010-80879.8079.878.5
  4.38%9.909.933075.275.2078.5
  6.08%9092207474078.5
  1.65%8.9-1.710.667176.576.77578.5
  5.80%8.608.622074.274.2078.5
  5.65%8.408.422074.374.3078.5
  5.44%8.108.122074.574.5078.5
  3.01%761-21377.5737978.5
  4.67%7072207575078.5
  4.38%6.62.44.202175.374.376.778.5
  0.89%6.206.299077.877.8078.5
  2.57%5.905.933076.576.5078.5
  3.84%5.805.822075.675.6078.5
  7.39%5.405.411073.173.1078.5
  1.05%4.904.966077.777.7078.5
  0.88%4.804.877077.877.8078.5
  0.85%4.6-1.86.467177.277.475.678.5
  0.81%4.43.90.6-51778.174.778.678.5
  2.75%4.204.222076.476.4078.5

券商虧損排行 - 2024/05/10 ~ 2024/05/17

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -2.49%-370.9-237-133.9-5713719476.977.976.278.5
  -1.68%-122.427.3-149.7-64329675.975.376.278.5
  -3.48%-104.75.6-110.3-3364075.174.375.378.5
  -5.21%-97.20-97.2-2502574.6074.678.5
  -4.53%-95.30-95.3-2802875.1075.178.5
  -2.45%-903.4-93.4-4714876.473.176.578.5
  -5.18%-88.90-88.9-2302374.67874.678.5
  -3.70%-700-70-2502575.7075.778.5
  -2.32%-69.50-69.5-3903976.7076.778.5
  -4.77%-58.6-45-13.6-3121676.778.875.178.5
  -5.15%-53.80-53.8-1401474.7074.778.5
  -2.26%-46.61.7-48.3-2432776.475.976.578.5
  -4.73%-46.10-46.1-130137507578.5
  -4.67%-420-42-120127507578.5
  -5.23%-390-39-1001074.6074.678.5
  -4.25%-38.4-11.6-26.8-751275.47774.778.5
  -0.46%-361.6-37.6-97410178.177.778.178.5
  -3.44%-33.9-3.7-30.2-1031375.776.775.578.5
  -4.93%-29.50-29.5-80874.8074.878.5
  -2.48%-28.50-28.5-1501576.6076.678.5
  -7.39%-27.2-4.5-22.7-41573.677.372.878.5
  -5.17%-270-27-70774.6074.678.5
  -1.38%-26.70-26.7-2502577.4077.478.5
  -5.61%-250-25-60674.3074.378.5
  -5.80%-21.50-21.5-50574.2074.278.5
  -1.97%-21.20-21.2-130147778.17778.5
  -3.32%-20.20-20.2-8087607678.5
  -4.81%-180-18-50574.9074.978.5
  -2.92%-17.80-17.8-80876.3076.378.5
  -5.94%-17.60-17.6-40474.1074.178.5
  -4.67%-17.50-17.5-5057507578.5
  -4.61%-17.30-17.3-5057507578.5
  -4.53%-170-17-50575.1075.178.5
  -2.43%-16.9-16.3-0.669377.278.673.278.5
  -7.39%-16.20-16.2-30373.1073.178.5
  -1.39%-16.20-16.2-1501577.4077.478.5
  -2.60%-13.90-13.9-70776.5076.578.5
  -2.28%-13.7-9.7-4-17875.175.974.578.5
  -2.91%-132.7-15.7-42674.273.274.678.5
  -5.23%-11.70-11.7-30374.6074.678.5
  -2.94%-11.20-11.2-50576.3076.378.5
  -4.67%-10.50-10.5-3037507578.5
  -1.31%-10.40-10.41010079.579.5078.5
  -2.64%-10.10-10.1-50576.5076.578.5
  -1.80%-9.70-9.7-70777.1077.178.5
  -6.59%-9.70-9.7-20273.7073.778.5
  -6.08%-90-9-2027407478.5
  -3.56%-8.10-8.1-30375.8075.878.5
  -0.23%-80-8-4404478.3078.378.5
  -4.95%-7.40-7.4-20274.8074.878.5
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音